OR9K2: A Potential Drug Target and Biomarker for Ovarian Cancer

Target Name: OR9K2

NCBI ID: G441639

OR9K2

OR9K2: A Potential Drug Target and Biomarker for Ovarian Cancer

Ovarian cancer is a leading cause of cancer death in women, with estimates suggesting that in the United States alone, over 21,000 women will be diagnosed with ovarian cancer in 2020. Despite advances in treatment, the survival rate for ovarian cancer remains relatively stagnant, with a five-year survival rate of only 50%. Therefore, there is a strong need for new and effective treatments for ovarian cancer.

One potential drug target for ovarian cancer is the OLPLN gene, which encodes a protein known as OR9K2. OR9K2 has been shown to be highly expressed in ovarian cancer tissues and cell lines, and has been associated with the development and progression of ovarian cancer.

In addition to its potential as a drug target, OR9K2 has also been identified as a potential biomarker for ovarian cancer. OR9K2 has been shown to be associated with the expression of other genes involved in cell signaling and growth, such as TGF-β1, ID4, and NF-kappa-B. Therefore, it may be possible to use OR9K2 as a biomarker for ovarian cancer, with the goal of developing new diagnostic tests or targeted therapies based on its expression levels.

The identification of OR9K2 as a potential drug target and biomarker for ovarian cancer is an exciting area of research, with implications for the treatment of ovarian cancer. Further studies are needed to determine the effectiveness of OR9K2 as a drug target and biomarker for ovarian cancer, as well as the best way to use it in clinical trials. However, the potential of OR9K2 as a drug target and biomarker for ovarian cancer is a promising area of research that could lead to new and more effective treatments for this devastating form of cancer.

Protein Name: Olfactory Receptor Family 9 Subfamily K Member 2

Functions: Odorant receptor

The "OR9K2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR9K2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets